Market Analysis and Insights: Global Non-Invasive Blood Glucose Monitoring Devices Market
The global Non-Invasive Blood Glucose Monitoring Devices market size is projected to reach US$ 21 million by 2027, from US$ 9 million in 2020, at a CAGR of 15.9% during 2021-2027.
Global Non-Invasive Blood Glucose Monitoring Devices Scope and Segment
The global Non-Invasive Blood Glucose Monitoring Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Invasive Blood Glucose Monitoring Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
MIR/NIR (Mid/Near Infrared Spectroscopy)
Raman Spectroscopy
Occlusion Spectroscopy
Optical Coherence Tomography
Photoacoustic Spectroscopy
Electromagnetic
Fluorescence
Other
By the end users/application, this report covers the following segments
Hospitals
Clinics
Home Care Settings
Other
Competitive Landscape:
The report provides a list of all the key players in the Non-Invasive Blood Glucose Monitoring Devices market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Non-Invasive Blood Glucose Monitoring Devices key manufacturers in this market include:
Abbott
BD Medical
Medtronic
Sanofi
Roche Diagnostics
Animas Technologies
Bayer Healthcare
Cercacor
Pendragon Medical
OrSense
Nova Biomedical
Dexcom
Terumo
Tosoh Bioscience
The global Non-Invasive Blood Glucose Monitoring Devices market size is projected to reach US$ 21 million by 2027, from US$ 9 million in 2020, at a CAGR of 15.9% during 2021-2027.
Global Non-Invasive Blood Glucose Monitoring Devices Scope and Segment
The global Non-Invasive Blood Glucose Monitoring Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Non-Invasive Blood Glucose Monitoring Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
MIR/NIR (Mid/Near Infrared Spectroscopy)
Raman Spectroscopy
Occlusion Spectroscopy
Optical Coherence Tomography
Photoacoustic Spectroscopy
Electromagnetic
Fluorescence
Other
By the end users/application, this report covers the following segments
Hospitals
Clinics
Home Care Settings
Other
Competitive Landscape:
The report provides a list of all the key players in the Non-Invasive Blood Glucose Monitoring Devices market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Non-Invasive Blood Glucose Monitoring Devices key manufacturers in this market include:
Abbott
BD Medical
Medtronic
Sanofi
Roche Diagnostics
Animas Technologies
Bayer Healthcare
Cercacor
Pendragon Medical
OrSense
Nova Biomedical
Dexcom
Terumo
Tosoh Bioscience
1 Non-Invasive Blood Glucose Monitoring Devices Market Overview
1.1 Non-Invasive Blood Glucose Monitoring Devices Product Overview
1.2 Non-Invasive Blood Glucose Monitoring Devices Market Segment by Type
1.2.1 MIR/NIR (Mid/Near Infrared Spectroscopy)
1.2.2 Raman Spectroscopy
1.2.3 Occlusion Spectroscopy
1.2.4 Optical Coherence Tomography
1.2.5 Photoacoustic Spectroscopy
1.2.6 Electromagnetic
1.2.7 Fluorescence
1.2.8 Other
1.3 Global Non-Invasive Blood Glucose Monitoring Devices Market Size by Type
1.3.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size Overview by Type (2016-2027)
1.3.2 Global Non-Invasive Blood Glucose Monitoring Devices Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Type (2016-2021)
1.4.2 Europe Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Type (2016-2021)
2 Global Non-Invasive Blood Glucose Monitoring Devices Market Competition by Company
2.1 Global Top Players by Non-Invasive Blood Glucose Monitoring Devices Sales (2016-2021)
2.2 Global Top Players by Non-Invasive Blood Glucose Monitoring Devices Revenue (2016-2021)
2.3 Global Top Players Non-Invasive Blood Glucose Monitoring Devices Price (2016-2021)
2.4 Global Top Manufacturers Non-Invasive Blood Glucose Monitoring Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Non-Invasive Blood Glucose Monitoring Devices Market Competitive Situation and Trends
2.5.1 Non-Invasive Blood Glucose Monitoring Devices Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Non-Invasive Blood Glucose Monitoring Devices Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-Invasive Blood Glucose Monitoring Devices as of 2020)
2.7 Date of Key Manufacturers Enter into Non-Invasive Blood Glucose Monitoring Devices Market
2.8 Key Manufacturers Non-Invasive Blood Glucose Monitoring Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Non-Invasive Blood Glucose Monitoring Devices Status and Outlook by Region
3.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Non-Invasive Blood Glucose Monitoring Devices Historic Market Size by Region
3.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Region (2016-2021)
3.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Region (2016-2021)
3.2.3 Global Non-Invasive Blood Glucose Monitoring Devices Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Region
3.3.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Region (2022-2027)
3.3.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Region (2022-2027)
3.3.3 Global Non-Invasive Blood Glucose Monitoring Devices Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Non-Invasive Blood Glucose Monitoring Devices by Application
4.1 Non-Invasive Blood Glucose Monitoring Devices Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Home Care Settings
4.1.4 Other
4.2 Global Non-Invasive Blood Glucose Monitoring Devices Market Size by Application
4.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size Overview by Application (2016-2027)
4.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Application (2016-2021)
4.3.2 Europe Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Application (2016-2021)
5 North America Non-Invasive Blood Glucose Monitoring Devices by Country
5.1 North America Non-Invasive Blood Glucose Monitoring Devices Historic Market Size by Country
5.1.1 North America Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2016-2021)
5.1.2 North America Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2016-2021)
5.2 North America Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Country
5.2.1 North America Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2022-2027)
5.2.2 North America Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2022-2027)
6 Europe Non-Invasive Blood Glucose Monitoring Devices by Country
6.1 Europe Non-Invasive Blood Glucose Monitoring Devices Historic Market Size by Country
6.1.1 Europe Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2016-2021)
6.1.2 Europe Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2016-2021)
6.2 Europe Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Country
6.2.1 Europe Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2022-2027)
6.2.2 Europe Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2022-2027)
7 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices by Region
7.1 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Historic Market Size by Region
7.1.1 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Region (2022-2027)
8 Latin America Non-Invasive Blood Glucose Monitoring Devices by Country
8.1 Latin America Non-Invasive Blood Glucose Monitoring Devices Historic Market Size by Country
8.1.1 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2016-2021)
8.1.2 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2016-2021)
8.2 Latin America Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Country
8.2.1 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2022-2027)
8.2.2 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2022-2027)
9 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices by Country
9.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Historic Market Size by Country
9.1.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Non-Invasive Blood Glucose Monitoring Devices Business
10.1 Abbott
10.1.1 Abbott Corporation Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Abbott Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.1.5 Abbott Recent Development
10.2 BD Medical
10.2.1 BD Medical Corporation Information
10.2.2 BD Medical Introduction and Business Overview
10.2.3 BD Medical Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Abbott Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.2.5 BD Medical Recent Development
10.3 Medtronic
10.3.1 Medtronic Corporation Information
10.3.2 Medtronic Introduction and Business Overview
10.3.3 Medtronic Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Medtronic Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.3.5 Medtronic Recent Development
10.4 Sanofi
10.4.1 Sanofi Corporation Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Sanofi Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.4.5 Sanofi Recent Development
10.5 Roche Diagnostics
10.5.1 Roche Diagnostics Corporation Information
10.5.2 Roche Diagnostics Introduction and Business Overview
10.5.3 Roche Diagnostics Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Roche Diagnostics Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.5.5 Roche Diagnostics Recent Development
10.6 Animas Technologies
10.6.1 Animas Technologies Corporation Information
10.6.2 Animas Technologies Introduction and Business Overview
10.6.3 Animas Technologies Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Animas Technologies Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.6.5 Animas Technologies Recent Development
10.7 Bayer Healthcare
10.7.1 Bayer Healthcare Corporation Information
10.7.2 Bayer Healthcare Introduction and Business Overview
10.7.3 Bayer Healthcare Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Bayer Healthcare Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.7.5 Bayer Healthcare Recent Development
10.8 Cercacor
10.8.1 Cercacor Corporation Information
10.8.2 Cercacor Introduction and Business Overview
10.8.3 Cercacor Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Cercacor Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.8.5 Cercacor Recent Development
10.9 Pendragon Medical
10.9.1 Pendragon Medical Corporation Information
10.9.2 Pendragon Medical Introduction and Business Overview
10.9.3 Pendragon Medical Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Pendragon Medical Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.9.5 Pendragon Medical Recent Development
10.10 OrSense
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Non-Invasive Blood Glucose Monitoring Devices Product Category, Application and Specification
10.10.3 OrSense Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 OrSense Recent Development
10.11 Nova Biomedical
10.11.1 Nova Biomedical Corporation Information
10.11.2 Nova Biomedical Introduction and Business Overview
10.11.3 Nova Biomedical Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Nova Biomedical Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.11.5 Nova Biomedical Recent Development
10.12 Dexcom
10.12.1 Dexcom Corporation Information
10.12.2 Dexcom Introduction and Business Overview
10.12.3 Dexcom Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Dexcom Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.12.5 Dexcom Recent Development
10.13 Terumo
10.13.1 Terumo Corporation Information
10.13.2 Terumo Introduction and Business Overview
10.13.3 Terumo Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Terumo Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.13.5 Terumo Recent Development
10.14 Tosoh Bioscience
10.14.1 Tosoh Bioscience Corporation Information
10.14.2 Tosoh Bioscience Introduction and Business Overview
10.14.3 Tosoh Bioscience Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Tosoh Bioscience Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.14.5 Tosoh Bioscience Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Non-Invasive Blood Glucose Monitoring Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Non-Invasive Blood Glucose Monitoring Devices Industrial Chain Analysis
11.4 Non-Invasive Blood Glucose Monitoring Devices Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Non-Invasive Blood Glucose Monitoring Devices Distributors
12.3 Non-Invasive Blood Glucose Monitoring Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Non-Invasive Blood Glucose Monitoring Devices Product Overview
1.2 Non-Invasive Blood Glucose Monitoring Devices Market Segment by Type
1.2.1 MIR/NIR (Mid/Near Infrared Spectroscopy)
1.2.2 Raman Spectroscopy
1.2.3 Occlusion Spectroscopy
1.2.4 Optical Coherence Tomography
1.2.5 Photoacoustic Spectroscopy
1.2.6 Electromagnetic
1.2.7 Fluorescence
1.2.8 Other
1.3 Global Non-Invasive Blood Glucose Monitoring Devices Market Size by Type
1.3.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size Overview by Type (2016-2027)
1.3.2 Global Non-Invasive Blood Glucose Monitoring Devices Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Type (2016-2021)
1.4.2 Europe Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Type (2016-2021)
2 Global Non-Invasive Blood Glucose Monitoring Devices Market Competition by Company
2.1 Global Top Players by Non-Invasive Blood Glucose Monitoring Devices Sales (2016-2021)
2.2 Global Top Players by Non-Invasive Blood Glucose Monitoring Devices Revenue (2016-2021)
2.3 Global Top Players Non-Invasive Blood Glucose Monitoring Devices Price (2016-2021)
2.4 Global Top Manufacturers Non-Invasive Blood Glucose Monitoring Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Non-Invasive Blood Glucose Monitoring Devices Market Competitive Situation and Trends
2.5.1 Non-Invasive Blood Glucose Monitoring Devices Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Non-Invasive Blood Glucose Monitoring Devices Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-Invasive Blood Glucose Monitoring Devices as of 2020)
2.7 Date of Key Manufacturers Enter into Non-Invasive Blood Glucose Monitoring Devices Market
2.8 Key Manufacturers Non-Invasive Blood Glucose Monitoring Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Non-Invasive Blood Glucose Monitoring Devices Status and Outlook by Region
3.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Non-Invasive Blood Glucose Monitoring Devices Historic Market Size by Region
3.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Region (2016-2021)
3.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Region (2016-2021)
3.2.3 Global Non-Invasive Blood Glucose Monitoring Devices Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Region
3.3.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Region (2022-2027)
3.3.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Region (2022-2027)
3.3.3 Global Non-Invasive Blood Glucose Monitoring Devices Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Non-Invasive Blood Glucose Monitoring Devices by Application
4.1 Non-Invasive Blood Glucose Monitoring Devices Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Home Care Settings
4.1.4 Other
4.2 Global Non-Invasive Blood Glucose Monitoring Devices Market Size by Application
4.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size Overview by Application (2016-2027)
4.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Non-Invasive Blood Glucose Monitoring Devices Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Application (2016-2021)
4.3.2 Europe Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales Breakdown by Application (2016-2021)
5 North America Non-Invasive Blood Glucose Monitoring Devices by Country
5.1 North America Non-Invasive Blood Glucose Monitoring Devices Historic Market Size by Country
5.1.1 North America Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2016-2021)
5.1.2 North America Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2016-2021)
5.2 North America Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Country
5.2.1 North America Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2022-2027)
5.2.2 North America Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2022-2027)
6 Europe Non-Invasive Blood Glucose Monitoring Devices by Country
6.1 Europe Non-Invasive Blood Glucose Monitoring Devices Historic Market Size by Country
6.1.1 Europe Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2016-2021)
6.1.2 Europe Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2016-2021)
6.2 Europe Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Country
6.2.1 Europe Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2022-2027)
6.2.2 Europe Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2022-2027)
7 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices by Region
7.1 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Historic Market Size by Region
7.1.1 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Region (2022-2027)
8 Latin America Non-Invasive Blood Glucose Monitoring Devices by Country
8.1 Latin America Non-Invasive Blood Glucose Monitoring Devices Historic Market Size by Country
8.1.1 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2016-2021)
8.1.2 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2016-2021)
8.2 Latin America Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Country
8.2.1 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2022-2027)
8.2.2 Latin America Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2022-2027)
9 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices by Country
9.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Historic Market Size by Country
9.1.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Non-Invasive Blood Glucose Monitoring Devices Business
10.1 Abbott
10.1.1 Abbott Corporation Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Abbott Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.1.5 Abbott Recent Development
10.2 BD Medical
10.2.1 BD Medical Corporation Information
10.2.2 BD Medical Introduction and Business Overview
10.2.3 BD Medical Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Abbott Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.2.5 BD Medical Recent Development
10.3 Medtronic
10.3.1 Medtronic Corporation Information
10.3.2 Medtronic Introduction and Business Overview
10.3.3 Medtronic Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Medtronic Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.3.5 Medtronic Recent Development
10.4 Sanofi
10.4.1 Sanofi Corporation Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Sanofi Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.4.5 Sanofi Recent Development
10.5 Roche Diagnostics
10.5.1 Roche Diagnostics Corporation Information
10.5.2 Roche Diagnostics Introduction and Business Overview
10.5.3 Roche Diagnostics Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Roche Diagnostics Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.5.5 Roche Diagnostics Recent Development
10.6 Animas Technologies
10.6.1 Animas Technologies Corporation Information
10.6.2 Animas Technologies Introduction and Business Overview
10.6.3 Animas Technologies Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Animas Technologies Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.6.5 Animas Technologies Recent Development
10.7 Bayer Healthcare
10.7.1 Bayer Healthcare Corporation Information
10.7.2 Bayer Healthcare Introduction and Business Overview
10.7.3 Bayer Healthcare Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Bayer Healthcare Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.7.5 Bayer Healthcare Recent Development
10.8 Cercacor
10.8.1 Cercacor Corporation Information
10.8.2 Cercacor Introduction and Business Overview
10.8.3 Cercacor Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Cercacor Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.8.5 Cercacor Recent Development
10.9 Pendragon Medical
10.9.1 Pendragon Medical Corporation Information
10.9.2 Pendragon Medical Introduction and Business Overview
10.9.3 Pendragon Medical Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Pendragon Medical Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.9.5 Pendragon Medical Recent Development
10.10 OrSense
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Non-Invasive Blood Glucose Monitoring Devices Product Category, Application and Specification
10.10.3 OrSense Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 OrSense Recent Development
10.11 Nova Biomedical
10.11.1 Nova Biomedical Corporation Information
10.11.2 Nova Biomedical Introduction and Business Overview
10.11.3 Nova Biomedical Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Nova Biomedical Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.11.5 Nova Biomedical Recent Development
10.12 Dexcom
10.12.1 Dexcom Corporation Information
10.12.2 Dexcom Introduction and Business Overview
10.12.3 Dexcom Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Dexcom Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.12.5 Dexcom Recent Development
10.13 Terumo
10.13.1 Terumo Corporation Information
10.13.2 Terumo Introduction and Business Overview
10.13.3 Terumo Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Terumo Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.13.5 Terumo Recent Development
10.14 Tosoh Bioscience
10.14.1 Tosoh Bioscience Corporation Information
10.14.2 Tosoh Bioscience Introduction and Business Overview
10.14.3 Tosoh Bioscience Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Tosoh Bioscience Non-Invasive Blood Glucose Monitoring Devices Products Offered
10.14.5 Tosoh Bioscience Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Non-Invasive Blood Glucose Monitoring Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Non-Invasive Blood Glucose Monitoring Devices Industrial Chain Analysis
11.4 Non-Invasive Blood Glucose Monitoring Devices Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Non-Invasive Blood Glucose Monitoring Devices Distributors
12.3 Non-Invasive Blood Glucose Monitoring Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
